Skip to main content

JANE STREET GROUP, LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1595888 NEW YORK, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
9 quarters on record

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Derivatives in KNSA

reported options exposure · as of Jun 30, 2026
CallValue
$3,127,155
CallShares
48,900
PutValue
$498,810
PutShares
7,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $557,642,679 across 56 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $498,810 7,800
2026-06-30 $3,127,155 48,900
2026-03-31 $1,998,225 41,500
2026-03-31 $269,640 5,600
2025-12-31 $10,000,237 242,430
2025-12-31 $255,750 6,200
2025-12-31 $779,625 18,900
2025-09-30 $17,915,695 461,388
2025-09-30 $275,693 7,100
2025-06-30 $15,450,706 558,392
2025-06-30 $774,760 28,000
2025-06-30 $312,671 11,300
2025-03-31 $2,871,552 129,291
2024-12-31 $3,747,359 189,452
2024-09-30 $8,623,848 345,092
2024-06-30 $553,303 29,636